Carfilzomib 60 mg is approved as a chemotherapy agent to treat patients with multiple myeloma who have taken single or multiple lines of therapy. The carfilzomib 60 mg injection price in India is less than the other countries due to the availability of both biosimilar drugs and their brand-name counterparts. The proposed dosing regimen of Carfilzomib 60 mg can be administered once or twice weekly, and your health specialist will determine which is appropriate for you.